TXG - 10x Genomics, Inc

Healthcare - Sector
Coverage

TXG is currently covered by 5 analysts with average potential upside of $20.11 (23.77%) backed by 16 price targets and 34 ratings. Analyst's average stock valuation to be materialised ratio is 63.52% with an average time for price targets to be met of 30.8 days.

Most recent stock forecast was given by TEJAS SAVANT from MORGAN STANLEY on 04-Nov-2022.

Highest price target for TXG is 191, Lowest price target is 27, average price target is 109.

Best performing analysts who are covering TXG - 10x Genomics, Inc:

Patrick B Donnelly Derik De Bruin Daniel Arias Matthew Sykes Tejas Savant

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average time for PT to be met

Performance score

Buy

64

$15.35 (31.55%)

70

2 months 24 days ago

1/7 (14.29%)

$30.64 (44.29%)

16

Sell

25

$-23.65 (-48.61%)

35

3 months 15 days ago

3/5 (60%)

$3.03 (7.37%)

9

Hold

35

$-13.65 (-28.06%)

6 months 13 days ago

5/6 (83.33%)

$14.37 (13.76%)

33

Buy

100

$64.16 (179.02%)

150

8 months 24 days ago

6/10 (60%)

$38.88 (42.64%)

55

Buy

200

$169.59 (557.68%)

150

1 years 11 months 11 days ago

3/3 (100%)

$13.65 (10.80%)

41

Show more analysts